Noveris Health Sciences is trading 8.7% down at CA$1.37 as the stock resumes its downward trajectory following a brief period of recovery.
- The stock had previously climbed 5.3% to CA$1.55 in a technical bounce, but those gains have since been erased.
- There have been no new company-specific announcements or regulatory filings since late June corporate updates.
- The current price action appears to be driven by ongoing market volatility and investor sentiment rather than fundamental news.